Philip B. Gorelick, MD MPH FACP is the John S. Garvin Professor and Head, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago (2003-present). Dr. Gorelick has received funding from the NIH since 1987 for such studies as the African American Antiplatelet Stroke Prevention Study, Risk Markers for Dementia After Stroke, and Neuroepidemiology of Multi-Infarct Dementia. His research focus has been identification of risk factors for stroke, first and recurrent stroke prevention, stroke prevention in high risk populations, and elucidating risk factors for vascular forms of cognitive impairment (VCI) and understanding mechanisms of VCI. Dr. Gorelick has received the Feinberg Award for Excellence in Clinical Stroke 2004 from the American Heart Association and the National Stroke Association (NSA) Visionary in Stroke Award. He has also held the Daniel Gainey Professorship 2005 at Mayo Clinic and the Henry Barnett 2005 Lectureship from the Canadian Stroke Network. He is a member of the Governor�s Illinois Task Force on Stroke. Dr. Gorelick has been cited by Good Housekeeping as one of the top Stroke Neurologists in the United States and is a member of the Goddess Fund Stroke Advisory Board, Board of Directors of the NSA, and Advisory Board for the American Stroke Association.

Karen C. Johnston, MD is the Harrison Distinguished Professor and Chair of Neurology and Professor of Public Health Sciences at the University of Virginia. She graduated from medical school at the University of Rochester School of Medicine in 1991. She did her neurology residency at the University of Rochester Strong Memorial Hospital and a vascular neurology fellowship at the University of Virginia. She joined the UVA faculty in 1997 and obtained a Master's degree in outcomes research and clinical investigation in 1999. She is board certified in General Neurology and Vascular Neurology. She was the Vice Chair of Research for the Department of Neurology prior to becoming Chair and is an Executive Leadership in Academic Medicine (ELAM) graduate from 2006.
Dr. Johnston's research has focused on treatment and outcomes in acute ischemic stroke and she is the principle investigator on numerous NIH funded grants. She participates in numerous NIH-NINDS study sections and data safety monitoring committees and is Chair of the NIH-NINDS Clinical Research Collaboration (CRC) advisory team. She was an Associate Editor of the journal Neurology and the founding editor of the Neurology Resident and Fellow section. She maintains a strong commitment to education and mentoring. She was the founding chair of the University of Virginia's Academy of Distinguished Educators and is the Director of the UVA internal K12 scholars program for career development in clinical and translational research. She is currently the director of the ANA Junior Faculty Career Development Symposium, the AAN Research Career Development Symposium and the NINDS Clinical Trials Methods Course Career Development Program.

Joseph Broderick, MD is Professor and Chairman of the Department of Neurology at the University of Cincinnati Medical Center since 2000 and a full-time member of the Department since 1987. He graduated from the University of Cincinnati Medical School in 1982 where he ranked first in his medical school class. He received his medical neurologic training and completed a Cerebrovascular fellowship at the Mayo Clinic in Rochester, MN. Dr. Broderick is an internationally recognized expert on the acute treatment of stroke and epidemiology of stroke and has had extensive involvement with hemorrhagic stroke. He is currently the Director of the Greater Cincinnati/Northern Kentucky Stroke Team and Cerebrovascular Research Program at the University of Cincinnati. He has received numerous awards including the 2003 William M. Feinberg Award for Excellence in Clinical Stroke from the Stroke Council of the American Stroke Association. He also has been named as one of the Best Heart & Stroke Physicians in the United States by Good Housekeeping and one of Best Doctors in America (National Survey � Woodward-White).

Professor J. Phillip Miller, PhD is the Director of the Biostatistics Core for the Alvin J. Siteman Cancer Center and the Biostatistics Core for the WU Alzheimer's Disease Research Center. He is Director of the coordinating center for the PKD Treatment Network (HALT-PKD), Co-Director of the coordinating center for the Ocular Hypertension Treatment Study (OHTS), Director of the coordinating center for the Extremity Constraint Induced Therapy Evaluation (EXCITE), and jointly directs the image analysis center/coordinating center for the NIDDK Polycystic Kidney Disease study (CRISP). Other current research projects include neuroimaging studies of schizophrenics and brain injured adults; imaging multi-drug resistance and modulation in breast cancer; an emergency room based intervention for childhood asthma; a health care delivery smoking cessation intervention; long-term follow-up of hypertensive veterans; frailty in the elderly; and cognitive rehabilitation following stroke and other neurological injury. He has previously directed coordinating centers on neuromuscular diseases, particularly Duchenne Dystrophy; frailty and injury interventions in the elderly; and post myocardial infarction interventions. Professor Miller is the Director of the WUBIOS Computing Resource for the Division of Biostatistics and was a founding member of the NIH Geriatrics and Rehabilitative Medicine study section.